Pharmaceutical Executive, June 2022 Issue (PDF)
2022 Pharm Exec Top 50 Companies
The Emergence of the Chief Value Officer in Healthcare
Sustainability Sea Change: The Top 5 ESG Challenges for Pharma
Is the C-Suite Getting Inflated?
Are We Closer Than Ever to a Biotech Bottom?
DE&I in Pharma: Good for People—and Business
Early Input Necessary in Creating Smooth C-Suite Transitions
A Storm in a Brussels Teacup Could Threaten Drug-Pricing Waters
Fresh Talent Awaits, But Must Be Tech-Savvy
FDA to Continue Inspection Efficiencies After Pandemic
How Regulatory Affairs Is Shaping Tomorrow’s Innovation Landscape